Globus Medical Inc Class A GMED

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

Globus Medical (GMED) has drawn investor attention after recent price moves left the stock down about 10% over the past month and roughly 5% lower over the past 3 months. Set against that short term pullback, Globus Medical’s 1 year total shareholder return of 32.5% and 3 year total shareholder return of 50.8% point to a very different picture from the recent 1 month share price decline of about 9.9% and 3 month share price drop of roughly 5.4%. This signals that momentum has cooled recently...

Over the last six months, Globus Medical’s shares have sunk to $74.94, producing a disappointing 10.3% loss - a stark contrast to the S&P 500’s 21.4% gain. This may have investors wondering how to approach the situation.